• SENSEX 80,710.25
    -308.47 (--0.38%)
  • BANKNIFTY 55,360.25
    -259.10 (--0.47%)
  • One 97
    1,050.95 481.75(%)
  • HDFC Bank
    1,967.00 1,593.20(%)
  • ICICI Bank
    1,440.95 1,153.30(%)
  • Aditya Infotech
    1,104.20 1,104.20(%)
  • Newgen Software
    968.75 1,795.50(%)
  • Godfrey Phillips
    9,891.25 9,891.25(%)
  • Reliance Industr
    1,388.10 1,115.55(%)
  • Jayaswal Neco
    55.85 55.85(%)
  • Tanla Platforms
    685.95 990.00(%)
  • Tata Inv.Corpn.
    7,625.00 8,075.90(%)
  • Infosys
    1,454.75 1,307.10(%)
  • KIOCL
    410.00 453.05(%)
  • APL Apollo Tubes
    1,633.60 1,935.00(%)
  • IndusInd Bank
    848.80 1,498.70(%)
  • Tata Motors
    659.00 1,142.00(%)
  • Chambal Fert.
    570.00 742.45(%)
  • Medplus Health
    865.95 603.00(%)
  • New India Assura
    205.00 278.00(%)
  • M & M
    3,221.15 3,302.90(%)
  • SBI
    803.65 875.50(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anthem Biosciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 33976.0
  • ISIN : INE0CZ201020
736.70 -16 (-2.07%)
  • As on 06 Aug 2025 (EOD)

  • Today’s Low

    734.00

  • Today’s High

    762.00

  • Open

    758.40

  • Perv Close

    752.30

  • 52W Low

    701.90

  • 52W High

    801.85

Key Indicators

  • P/E(TTM)

    81.59

  • Mar.Cap (₹Cr.)

    41,373.81

  • Div & Yield %

    0.00

  • Book Value(₹)

    44.05

  • Debt-Equity Ratio

    -2.07

  • AGM Date

    05-Aug-2025

  • EPS

    9.02

  • P/E Ratio

    81.59

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    41,373.81

  • RONW (%)

    20.04

  • ROCE (%)

    23.98

Score Board

  • Equity (₹ in Cr.)

    112.32

  • BV (₹)

    44.00

  • Sales( ₹ in Cr.)

    1,840.65

  • NP (in Cr.)

    506.45

  • NP Var(%)

    35.0

  • Div%

    0.0

  • CPS (₹)

    10.40

  • EPS (₹)

    9.00

  • Traded Value (₹ in Lakhs)

    41,331.69

  • 52 Week High

    801.85

  • 52 Week Low

    701.90

  • Price BSE

    736.0

  • Price NSE

    737.00

  • Market Capital( in Cr.)

    41,331.69

  • P/C Ratio

    70.70

  • P/E Ratio

    81.60

  • Price Vs.BV

    9.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24 632.72
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,840.65 1,417.54 1,056.92 1,231.26 1,103.24 632.72
Other Income 109.44 70.52 139.17 48.98 37.21 20.76
Stock Adjustments 86.70 41.23 9.01 1.37 -39.12 37.86
Total Income 2,036.79 1,529.29 1,205.10 1,281.61 1,101.33 691.34
EXPENDITURE :            
Raw Materials 828.08 640.77 348.29 410.30 407.88 284.29
Power and Fuel Cost 42.56 31.29 38.95 36.32 34.23 30.42
Employee Cost 251.76 182.65 153.24 137.51 142.19 120.15
Other Manufacturing Expenses 46.27 34.13 21.11 23.38 22.76 14.46
Selling and Administration Expenses 56.41 54.67 60.66 48.21 33.66 31.83
Miscellaneous Expenses 13.08 10.25 12.68 11.46 15.67 7.52
Employee Benefit Expenses 251.76 182.65 153.24 137.51 142.19 120.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,238.15 953.77 634.92 667.18 656.38 488.66
Operating Profit 798.65 575.52 570.19 614.44 444.95 202.68
Interest 9.29 9.26 8.71 10.09 16.97 20.43
Gross Profit 789.36 566.26 561.48 604.35 427.98 182.25
Depreciation 77.94 81.49 63.70 57.76 62.40 61.58
Profit Before Tax 711.42 484.77 497.78 546.59 365.58 120.67
Current Tax 182.03 126.41 120.05 142.39 96.70 33.25
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 23.21 -16.42 -7.94 -1.79 -2.43 -5.29
Reported Net Profit 506.19 374.78 385.67 405.99 271.31 92.70
Extraordinary Items -0.26 -0.21 40.84 -0.14 -0.14 0.06
Adjusted Net Profit 506.45 374.99 344.83 406.13 271.45 92.64
Adjustment below Net Profit -50.62 -71.60 -139.35 0.00 0.00 0.00
P & L Balance brought forward 1,524.15 1,220.97 974.65 568.66 362.71 270.38
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 26.08 0.37
P & L Balance carried down 1,979.72 1,524.15 1,220.97 974.65 607.93 362.71
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 9.05 6.70 6.76 462.60 319.76 110.63
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 44.24 34.58 30.53 1,544.46 826.76 503.43
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    74.69%

  • Public Share Holding

    25.31%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 408,054,643 72.66 408,054,643 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 11,409,736 2.03 11,409,736 2
Others 0 0.00 0 0
Sub Total 419,464,379 74.69 419,464,379 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 4,237,505 0.75 4,237,505 35
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,415,872 1.50 8,415,872 83
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,160,038 0.38 2,160,038 25
Mutual Funds / UTI 12,399,519 2.21 12,399,519 21
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,465,001 0.26 1,465,001 56
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 28,677,935 5.11 28,677,935 220
2] Non Institution
Bodies Corporate 22,407,534 3.99 22,407,534 201
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 44,440 0.01 44,440 812
Foreign Non Institution Other 15,396,327 2.74 15,396,327 1
Hindu Undivided Families 1,595,487 0.28 1,595,487 20,583
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 43,327,280 7.71 43,327,280 5
Individuals holding nominal share capital up to Rs. 1 lakh 30,696,305 5.47 30,696,305 804,012
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 364 0.00 364 1
Others 0 0.00 0 0
Sub Total 113,467,737 20.20 113,467,737 825,615
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 561,610,051 100.00 561,610,051 825,844

Company Background

Anthem Biosciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Anthem Biosciences Ltd
  • BSE Code : 33976.0
  • ISIN : INE0CZ201020

  • Incorporation Year

    2006

  • Registered Office

    49 F1 & F2 Canara Bank Road
    Bommasandra Industrial Area, Bangalore,
    Karnataka-560099

  • Telephone

    +91 080 6672 4000

  • FAX

  • Chairman

    Ajay Bhardwaj

  • Managing Director

  • Company Secretary

    Divya Prasad

  • Auditor

    K P Rao & Co

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Anthem Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anthem Bioscienc 735.95 1,950.09 1,840.65 81.68 30.46
Abbott India 33,260.70 6,684.73 6,409.15 49.97 44.95
Astrazeneca Phar 8,853.35 1,756.92 1,716.29 191.22 32.94
P & G Health Ltd 6,185.55 1,166.89 1,151.26 34.16 39.76
Glaxosmi. Pharma 2,840.30 3,866.05 3,723.49 51.08 58.72
Cipla 1,499.25 20,029.57 19,044.85 22.41 21.40
Amrutanjan Healt 688.35 437.58 421.23 39.16 20.84
Fermenta Biotec. 360.00 442.21 430.53 15.67 17.61
Guj. Themis Bio. 358.25 174.19 169.82 87.59 44.82
Bliss GVS Pharma 179.40 703.42 667.20 26.82 9.16
Ambalal Sarabhai 32.11 19.33 4.04 29.73 2.10